Free Trial

Can-Fite BioPharma (CANF) Institutional Ownership

Can-Fite BioPharma logo
$0.63 -0.03 (-4.84%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$0.64 +0.01 (+2.15%)
As of 08/29/2025 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Can-Fite BioPharma (NYSE:CANF)

Current
Institutional Ownership
Percentage
21.00%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$90.78K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$16.53K
Get CANF Insider Trade Alerts

Want to know when executives and insiders are buying or selling Can-Fite BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CANF Institutional Buying and Selling by Quarter

Can-Fite BioPharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/29/2025 Rhumbline Advisers38,268$57K0.0%+42.4%1.081%
4/8/2025 Rhumbline Advisers38,268$57K0.0%+42.4%1.081%
2/17/2025 BNP Paribas Financial Markets25,185$41K0.0%N/A0.711%
2/14/2025 Two Sigma Securities LLC19,395$32K0.0%-34.4%0.548%
1/30/2025 Rhumbline Advisers26,880$44K0.0%+58.6%0.759%
8/15/2024 Armistice Capital LLC518,853$1.34M0.0%+35.5%14.657%
2/13/2024 Armistice Capital LLC154,363$340K0.0%N/A4.361%
1/17/2024Schechter Investment Advisors LLC20,077$44K0.0%N/A0.567%
2/10/2022 Acadian Asset Management LLC28,601$36K0.0%-75.1%0.105%
11/16/2021Cetera Advisor Networks LLC130,776$217K0.0%-16.9%0.607%
10/15/2021 Fifth Third Bancorp30,000$50K0.0%N/A0.149%
8/6/2021 StoneX Group Inc.40,000$91K0.0%N/A0.233%
(Data available from 1/1/2016 forward)

CANF Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CANF shares?

During the previous two years, the following institutional investors and hedge funds held shares of Can-Fite BioPharma shares: Armistice Capital LLC ($1.34M), Rhumbline Advisers ($57K), Schechter Investment Advisors LLC ($44K), and BNP Paribas Financial Markets ($41K), Two Sigma Securities LLC ($32K).Learn more on Can-Fite BioPharma's institutional investors.

What percentage of Can-Fite BioPharma's stock is owned by institutional investors?

21.00% of Can-Fite BioPharma's stock is owned by institutional investors. Learn more on CANF's institutional investor holdings.

Which institutional investors have been buying Can-Fite BioPharma's stock?

The following institutional investors have purchased Can-Fite BioPharma's stock in the last 24 months: Armistice Capital LLC ($290.42K), Rhumbline Advisers ($32.71K), BNP Paribas Financial Markets ($25.19K), and Schechter Investment Advisors LLC ($20.08K).

How much institutional buying is happening at Can-Fite BioPharma?

Institutional investors have bought a total of 57,896 shares in the last 24 months. This purchase volume represents approximately $90.78K in transactions.

Which of Can-Fite BioPharma's major shareholders have been selling company stock?

The following institutional investors have sold Can-Fite BioPharma stock in the last 24 months: Two Sigma Securities LLC ($10.18K).

How much institutional selling is happening at Can-Fite BioPharma?

Institutional investors have sold a total of 10,175 shares in the last 24 months. This volume of shares sold represents approximately $16.53K in transactions.



This page (NYSE:CANF) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners